Xoma reported $-4368000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US USD -39945000 3.34M
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Bluebird Bio BLUE:US USD -85093000 14.32M
Chimerix CMRX:US USD 11.67M 35.09M
Eli Lilly And LLY:US USD 2.31B 308.9M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Life Technologies LIFE:US USD -13443000 922K
Macrogenics MGNX:US USD -22111000 16.82M
Novartis NOVN:VX USD 4.69B 34M
Novartis NVS:US USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Xoma XOMA:US USD -4368000 398K
YTE INCY:US USD 134.94M 141.85M